ENTRY       D09569                      Drug
NAME        Ezogabine (USAN);
            Retigabine (INN);
            Potiga (TN)
FORMULA     C16H18FN3O2
EXACT_MASS  303.1383
MOL_WEIGHT  303.3314
CLASS       Neuropsychiatric agent
             DG03199  Antiepileptic agent
              DG02037  GABA mimetic antiepileptic
            Transporter inhibitor
             DG01622  ABCB1 inhibitor
             DG02866  SLC22A8 inhibitor
REMARK      Same as: C13826
            ATC code: N03AX21
EFFICACY    Antiepileptic
COMMENT     Adjunctive therapy for partial onset seizures
TARGET      KCNQ [HSA:3784 3785 3786 9132 56479] [KO:K04926 K04927 K04928 K04929 K04930]
  PATHWAY   hsa04725(3784+3785+3786+56479+9132)  Cholinergic synapse
INTERACTION Transporter inhibition: SLC22A8 [HSA:9376], ABCB1 [HSA:5243]
STR_MAP     map07232  Potassium channel blocking and opening drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N03 ANTIEPILEPTICS
               N03A ANTIEPILEPTICS
                N03AX Other antiepileptics
                 N03AX21 Retigabine
                  D09569  Ezogabine (USAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               DG02037  GABA mimetic antiepileptic
                D09569  Ezogabine
             Transporter inhibitor
              DG01622  ABCB1 inhibitor
               D09569  Ezogabine
              DG02866  SLC22A8 inhibitor
               D09569  Ezogabine
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Potassium channels
                KCNQ
                 D09569  Ezogabine (USAN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D09569
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D09569
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09569
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug transporters
              D09569
DBLINKS     CAS: 150812-12-7
            PubChem: 124490309
            ChEBI: 68584
            PDB-CCD: FBX
            LigandBox: D09569
ATOM        22
            1   C8x C    17.0100  -26.2500
            2   C8y C    17.0100  -27.6500
            3   C8x C    18.2700  -28.3500
            4   C8x C    19.4600  -27.6500
            5   C8y C    19.4600  -26.2500
            6   C8x C    18.2700  -25.5500
            7   C1b C    20.6500  -25.5500
            8   N1b N    21.9100  -26.2500
            9   C8y C    23.1000  -25.5500
            10  C8x C    24.2900  -26.2500
            11  C8y C    25.5500  -25.5500
            12  C8y C    25.5500  -24.1500
            13  C8x C    24.2900  -23.4500
            14  C8x C    23.1000  -24.1500
            15  N1b N    26.7400  -23.4500
            16  C7a C    27.9300  -24.1500
            17  O7a O    29.1900  -23.4500
            18  C1b C    30.3800  -24.1500
            19  C1a C    31.5700  -23.4500
            20  O6a O    27.9300  -25.5500
            21  N1a N    26.7400  -26.2500
            22  X   F    15.8200  -28.3500
BOND        23
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     5   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12   11  12 2
            13   12  13 1
            14   13  14 2
            15    9  14 1
            16   12  15 1
            17   15  16 1
            18   16  17 1
            19   17  18 1
            20   18  19 1
            21   16  20 2
            22   11  21 1
            23    2  22 1
///
